Fuller & Thaler Asset Management’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $158M | Sell |
1,220,539
-45,260
| -4% | -$6.51M | 0.53% | 49 |
|
|
2025
Q4 | $181M | Sell |
1,265,799
-119,356
| -9% | -$16M | 0.61% | 42 |
|
|
2025
Q3 | $166M | Sell |
1,385,155
-4,811
| -0.3% | -$610K | 0.56% | 49 |
|
|
2025
Q2 | $184M | Buy |
1,389,966
+6,743
| +0.5% | +$914K | 0.67% | 29 |
|
|
2025
Q1 | $192M | Sell |
1,383,223
-11,455
| -0.8% | -$1.78M | 0.75% | 26 |
|
|
2024
Q4 | $216M | Sell |
1,394,678
-17,966
| -1% | -$3.04M | 0.82% | 23 |
|
|
2024
Q3 | $257M | Sell |
1,412,644
-106,530
| -7% | -$15.8M | 1.01% | 15 |
|
|
2024
Q2 | $180M | Sell |
1,519,174
-15,568
| -1% | -$1.64M | 0.77% | 27 |
|
|
2024
Q1 | $165M | Buy |
1,534,742
+62,692
| +4% | +$6.23M | 0.72% | 28 |
|
|
2023
Q4 | $147M | Buy |
1,472,050
+457,044
| +45% | +$44.7M | 0.74% | 31 |
|
|
2023
Q3 | $121M | Buy |
1,015,006
+377,532
| +59% | +$56.3M | 0.69% | 38 |
|
|
2023
Q2 | $114M | Sell |
637,474
-32,869
| -5% | -$6.03M | 0.65% | 49 |
|
|
2023
Q1 | $111M | Buy |
670,343
+91,810
| +16% | +$15.8M | 0.64% | 52 |
|
|
2022
Q4 | $91.1M | Buy |
578,533
+41,756
| +8% | +$6.35M | 0.58% | 57 |
|
|
2022
Q3 | $80.8M | Buy |
536,777
+200,649
| +60% | +$33.4M | 0.58% | 58 |
|
|
2022
Q2 | $55.3M | Buy |
+336,128
| New | +$64.7M | 0.38% | 94 |
|
|
2019
Q3 | – | Sell |
-7,344
| Closed | -$1.85M | – | 482 |
|
|
2019
Q2 | $1.85M | Sell |
7,344
-1,103
| -13% | -$256K | 0.02% | 298 |
|
|
2019
Q1 | $2.02M | Sell |
8,447
-1,777
| -17% | -$426K | 0.03% | 279 |
|
|
2018
Q4 | $2.35M | Sell |
10,224
-2,706
| -21% | -$667K | 0.03% | 253 |
|
|
2018
Q3 | $3.66M | Sell |
12,930
-1,400
| -10% | -$410K | 0.04% | 248 |
|
|
2018
Q2 | $4.21M | Sell |
14,330
-3,809
| -21% | -$1.04M | 0.05% | 234 |
|
|
2018
Q1 | $4.58M | Buy |
18,139
+10
| +0.1% | +$2.35K | 0.05% | 208 |
|
|
2017
Q4 | $3.92M | Buy |
18,129
+1,179
| +7% | +$239K | 0.05% | 193 |
|
|
2017
Q3 | $3.15M | Sell |
16,950
-650
| -4% | -$113K | 0.04% | 205 |
|
|
2017
Q2 | $3.04M | Sell |
17,600
-1,200
| -6% | -$193K | 0.04% | 188 |
|
|
2017
Q1 | $2.87M | Buy |
18,800
+2,300
| +14% | +$336K | 0.04% | 186 |
|
|
2016
Q4 | $2.43M | Buy |
16,500
+3,400
| +26% | +$492K | 0.04% | 189 |
|
|
2016
Q3 | $1.66M | Sell |
13,100
-60,685
| -82% | -$7.32M | 0.03% | 211 |
|
|
2016
Q2 | $8.32M | Sell |
73,785
-17,050
| -19% | -$1.77M | 0.14% | 108 |
|
|
2016
Q1 | $9.46M | Buy |
90,835
+9,400
| +12% | +$899K | 0.18% | 99 |
|
|
2015
Q4 | $9.18M | Sell |
81,435
-500
| -0.6% | -$55.3K | 0.2% | 96 |
|
|
2015
Q3 | $8.97M | Buy |
81,935
+27,200
| +50% | +$2.91M | 0.23% | 95 |
|
|
2015
Q2 | $5.24M | Hold |
54,735
| – | – | 0.15% | 129 |
|
|
2015
Q1 | $5.1M | Sell |
54,735
-5
| -0% | -$437 | 0.16% | 128 |
|
|
2014
Q4 | $4.48M | Buy |
+54,740
| New | +$4.2M | 0.16% | 143 |
|
Other funds holding ICUI
VPM
VCM
RRAM
Fuller & Thaler Asset Management's ICUI Position: Q1 2026 in Review
Fuller & Thaler Asset Management reduced its ICU Medical (ICUI) stake by 3.6% in Q1 2026, selling an estimated $6.51M and leaving 1,220,539 shares worth $158M. The position accounts for 0.53% of the portfolio, ranked #49.
Fuller & Thaler Asset Management first reported a position in ICUI in Q4 2014 and has held it in 35 quarters since. The position peaked at $257M in Q3 2024. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- Fuller & Thaler Asset Management held 1,220,539 shares of ICU Medical worth $158M as of Q1 2026.
- Fuller & Thaler Asset Management sold 45,260 ICU Medical shares in Q1 2026, an estimated $6.51M.
- ICU Medical made up 0.53% of Fuller & Thaler Asset Management's portfolio in Q1 2026, its #49 holding.
- Fuller & Thaler Asset Management first reported a position in ICU Medical in Q4 2014 and has held it in 35 quarters since.
- Fuller & Thaler Asset Management's ICU Medical position peaked at $257M in Q3 2024.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on Fuller & Thaler Asset Management's 13F filing for Q1 2026, filed 14 May 2026.